期刊文献+

α-1,3-N-乙酰半乳糖胺等位基因421T〉C突变导致A抗原弱表达 被引量:4

Identification of a novel T421C mutation of α-1,3-N-acetylgalactosaminyltransferase allele responsible for an A variant
原文传递
导出
摘要 目的探讨1例ABO血型系统A变异型的分子遗传学背景。方法采用血清学方法鉴定ABO血型,测定血浆α-1,3-N-乙酰半乳糖胺转移酶的活性,用PCR扩增AB0基因的7个外显子及启动子序列,测序分析第7外显子单倍体。结果先证者红细胞ABO血型为A弱表现型,AB0基因全编码区测序发现8处核苷酸杂合位点,分别为第6外显子的261delG缺失和297A/G、第7外显子的421c/T、467C/T、646T/A、681G/A、771C/T以及829G/A杂合变异。单链测序分析提示,其中1条为002等位基因,另一个等位基因除421T〉C和467C〉T突变外,其他变异位点与A101等位基因一致。421T〉C突变可导致A糖基转移酶第141位丝氨酸替换为脯氨酸(Serl41Pro)。结论产生弱A表型的原因可能是由于A糖基转移酶基因421T〉C突变引起编码的氨基酸改变,使α-1,3-N乙酰半乳糖胺转移酶活性减弱,导致A抗原弱表达。 Objective To investigate the molecular basis of an individual featuring weak A phenotype of ABO blood group system. Methods Serologic investigations, serum transferases activity assay and absorption elution test were carried out to identify the ABO blood group. The 7 exons and flanking introns of ABO glycosyltransferase gene were amplified with polymerase chain reaction (PCR). The products were sequenced bidirectinally following enzyme digestion. Haplotypes of exons 6 and 7 of the ABO gene were analyzed. Results A weak A antigen was identified on red blood cells of the proband. Eight heterozygous sites in exons 6 and 7 (261delG 297A/G, 421C/T, 467C/T, 646T/A, 681G/A, 771C/T, 829G/A) of the ABO gene were identified. Based on haplotype analysis, one allele was determined as 002, while a novel mutation 421T〉C was identified in another allele, which resulted in the amino acid change Ser141Pro of the A glycosyltransferase. Conclusion Above results suggested that amino acid substitutions resulted from a novel mutation 421T〉C of the ABO gene may decrease the enzymatic activity and result in the weak A phenotype.
机构地区 陕西省血液中心
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2015年第1期105-108,共4页 Chinese Journal of Medical Genetics
关键词 ABO血型 弱表现型 α-1 3 N-乙酰半乳糖胺基转移酶 ABO blood group Weak A phenotype α-1,3 N acetylgalactosaminyltransferase
  • 相关文献

参考文献13

  • 1童军,刘庆海,杨文冲.血型血清学实验方法//李勇,马学严.实用血液免疫学血型理论和实验技术.北京:科学出版社,2006.588-589.
  • 2Ohrmori T* Sato H. Improvement of ahsorption-elution testusing commercially available anti-A, anti-B monoclonalantibodies-ABO blood typing from hair sample C J ]. NihonHoigaku Zasshi, 1999, 53(3): 338-344.
  • 3Nagai M, Dave V,Kaplan BP:,et al. Human blood groupglycosyltransf erases. Purification of N-aceiylgalactosaminyltransferase[J]. J Bio Chem, 1978,253(2) :377-379.
  • 4胡文健,傅广成,许先国,朱发明,吕杭军,严力行.一种ABx变异型相关的B糖基转移酶基因新突变研究[J].中华医学遗传学杂志,2012,29(5):566-569. 被引量:7
  • 5Yamamoto F, Markcn J, Tsuji T, et al. Cloning andcharacterization of DNA complementary to human UDP-GalNac:Fuc alpha 1-2 Gal alpha 1-3 GalNAc transferase ( histo-bloodgroup A transferase) mRNA[J]. J Bio Chem,1990,256 ( 2):1146-1151.
  • 6Morgan WT,Watkins WM. Unraveling the biochemical basis ofblood group ABO and Lewis antigenic specificity[J]. GlycoconjJ, 2000, 17(5-9): 501-530.
  • 7Bennett EP, Steffensen R, Clausen H,et al. Genomic cloning ofthe human histo-blood group ABO locus [J ]. Biochem BiophysRes Commun, 1995,206( 1): 318-325.
  • 8Ogasawara K,Yabe R,Uchikawa M, et al. Recombination andgene conversion- like events may contribute to ABO genediversity causing various phenotypes [J], Immunogenctics,2001, 53(3): 190-199.
  • 9Olsson ML, Chester MA. Polymorphism and recombinationevents at the ABO locus: a major challenge for genomic ABOblood grouping strategies[J]. Transfus Med. 2001,11(4): 295..313.
  • 10Ogasawara K,Yabe R, Uchikawa M,et al. Molecular geneticanalysis of variant phenotypes of the ABO blood group system[J]. Blood, 1996, 88(7): 2732-2337.

二级参考文献26

  • 1许先国,洪小珍,刘瑛,吴俊杰,马开荣,朱发明,严力行.α1,3半乳糖基转移酶新等位基因278C>T的鉴定[J].中华医学遗传学杂志,2006,23(6):631-634. 被引量:30
  • 2NAGAI M, DAVE V, KAPLAN B E, et al. Human blood group glycosyltransferases. I. Purification of N Eacetylgalactosaminyltransferase [J]. J Biol Chem, 1978,253: 377--9.
  • 3CAI XH,JIN S,LIU X,et al. Molecular genetic anal ysis for the B(x) subgroup revealing two novel alleles in the ABO gene [J]. Transfusion,2008, 48; 2442-- 2447.
  • 4LI L,YANG MH,CHAK KF,et al. Three missense mutations, including a novel 860C>T transition, and allelic enhancement phenomenon associated with ABO blood subgroups A in Taiwan[J]. Transfusion,2007, 47:1014--1021.
  • 5MORGAN W T, WATKINS W M. Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity [J]. Glycoconj J 2000;17:501--30.
  • 6YAMAMOTO F, CLAUSEN H, WHITE T, et al. Molecular genetic basis of the histo- blood group ABO system [J]. Nature, 1990,345 : 229-- 233.
  • 7BENNETT E P, STEFFENSEN R, CLAUSEN H, et al. Genomic cloning of the human histo--blood group ABO locus [J].Biochem Biophys Res Commun, 1995,206:318--325.
  • 8SELTSAM A, HALLENSLEBEN M, EIZ-VESPER B,et al. A weak blood group A phenotype caused by a new mutation at the ABO locus [J].Transfusion, 2002;42:294--301.
  • 9OLSSON M L,CHESTER M A. Frequent occurrence of a variant O1 gene at the blood group ABO locus [J]. VoxSang,1996; 70:26--30.
  • 10DANIELS G. Human blood groups [M]. Oxford: Blackwell Scientific, Second edition, 2002:

共引文献25

同被引文献12

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部